74
Views
0
CrossRef citations to date
0
Altmetric
CLINICAL TRIAL REPORT

Safety of an Intracameral Fixed Combination for Mydriasis and Intraocular Anaesthesia During Cataract Surgery

, , , , &
Pages 1103-1115 | Received 04 Dec 2023, Accepted 08 Apr 2024, Published online: 26 Apr 2024

References

  • Wang W, Yan W, Fotis K, et al. Cataract surgical rate and socioeconomics: a global study. Invest Ophthalmology Visual Science. 2016;57(14):5872–5881. doi:10.1167/iovs.16-19894
  • Ellwein LB, Lepkowski JM, Thulasiraj RD, Brilliant GE. The cost effectiveness of strategies to reduce barriers to cataract surgery. Operat Res Group. Int Ophthalmol. 1991;15(3):175–183.
  • Boisjoly H, Freeman EE, Djafari F, et al. Reducing wait time for cataract surgery: comparison of 2 historical cohorts of patients in Montreal. Can J Ophthalmol. 2010;45(2):135–139. doi:10.3129/i09-256
  • Bernhisel A, Pettey J. Manual small incision cataract surgery. Curr Opin Ophthalmol. 2020;31(1):74–79. doi:10.1097/ICU.0000000000000624
  • Greenberg PB, Tseng VL, W-C W, et al. Prevalence and predictors of ocular complications associated with cataract surgery in United States veterans. Ophthalmology. 2011;118(3):507–514. doi:10.1016/j.ophtha.2010.07.023
  • Jaycock P, Johnston RL, Taylor H, et al. The cataract national dataset electronic multi-centre audit of 55,567 operations: updating benchmark standards of care in the United Kingdom and internationally. Eye. 2009;23(1):38–49. doi:10.1038/sj.eye.6703015
  • Behndig A, Montan P, Stenevi U, Kugelberg M, Lundstrom M. One million cataract surgeries: Swedish national cataract register 1992-2009. J Cataract Refract Surg. 2011;37(8):1539–1545. doi:10.1016/j.jcrs.2011.05.021
  • Zaidi FH, Corbett MC, Burton BJL, Bloom PA. Raising the benchmark for the 21st century--The 1000 cataract operations audit and survey: outcomes, consultant-supervised training and sourcing NHS choice. British J Ophthalmology. 2007;91(6):731–736. doi:10.1136/bjo.2006.104216
  • Lundström M, Barry P, Henry Y, Rosen P, Stenevi U. Evidence-based guidelines for cataract surgery: guidelines based on data in the European registry of quality outcomes for cataract and refractive surgery database. J Cataract Refractive Surg. 2012;38(6):1086–1093. doi:10.1016/j.jcrs.2012.03.006
  • Stein JD, Grossman DS, Mundy KM, Sugar A, Sloan FA. Severe adverse events after cataract surgery among medicare beneficiaries. Ophthalmology. 2011;118(9):1716–1723. doi:10.1016/j.ophtha.2011.02.024
  • Segers MHM, Behndig A, van den Biggelaar FJHM, et al. Outcomes of cataract surgery complicated by posterior capsule rupture in the European registry of quality outcomes for cataract and refractive surgery. J Cataract Refractive Surg. 2022;48(8):942–946. doi:10.1097/j.jcrs.0000000000000901
  • Wielders LHP, Schouten JSAG, Winkens B, et al. ESCRS PREMED study group. randomized controlled European multicenter trial on the prevention of cystoid macular edema after cataract surgery in diabetics: ESCRS PREMED study report 2. J Cataract Refract Surg. 2018;44(7):836–847. doi:10.1016/j.jcrs.2018.05.015
  • Wielders LHP, Schouten JSAG, Winkens B, et al.; ESCRS PREMED Study Group. European multicenter trial of the prevention of cystoid macular edema after cataract surgery in nondiabetics: ESCRS PREMED study report 1. J Cataract Refract Surg. 2018;44(4):429–439. doi:10.1016/j.jcrs.2018.01.029
  • Ganekal S, Nagarajappa A. Comparison of morphological and functional endothelial cell changes after cataract surgery: phacoemulsification versus manual small-incision cataract surgery. Mid East African J Ophthalmology. 2014;21(1):56–60. doi:10.4103/0974-9233.124098
  • Rosado-Adames N, Afshari NA. The changing fate of the corneal endothelium in cataract surgery. Curr Opinion Ophthalmology. 2012;23(1):3–6. doi:10.1097/ICU.0b013e32834e4b5f
  • Rengstorff RH, Doughty CB. Mydriatic and cycloplegic drugs: a review of ocular and systemic complications. Am J Optom Physiol Opt. 1982;59(2):162–177. doi:10.1097/00006324-198202000-00008
  • Zakrzewski PA, Banashkevich AV, Friel T, Braga-Mele R. Monitored anesthesia care by registered respiratory therapists during cataract surgery: an update. Ophthalmology. 2010;117(5):897–902. doi:10.1016/j.ophtha.2009.10.005
  • Behndig A, Korobelnik JF. Mydriatic insert and intracameral injections compared with mydriatic eyedrops in cataract surgery: Controlled studies. J Cataract Refract Surg. 2015;41(7):1503–1519. doi:10.1016/j.jcrs.2014.12.050
  • Fraunfelder FW, Rich LF. Possible adverse effects of drugs used in refractive surgery. J Cataract Refract Surg. 2003;29(1):170–175. doi:10.1016/S0886-3350(02)01836-9
  • Lundberg B, Behndig A. Intracameral mydriatics in phacoemulsification cataract surgery. J Cataract Refract Surg. 2003;29(12):2366–2371. doi:10.1016/S0886-3350(03)00522-4
  • Behndig A, Cochener-Lamard B, Guell J, et al. Surgical, antiseptic, and antibiotic practice in cataract surgery: Results from the European observatory in 2013. J Cataract Refract Surg. 2015;41(12):2635–2643. doi:10.1016/j.jcrs.2015.06.031
  • Behndig A, Linden C. Aqueous humor lidocaine concentrations in topical and intracameral anesthesia. J Cataract Refract Surg. 1998;24(12):1598–1601. doi:10.1016/S0886-3350(98)80349-0
  • Behndig A, Eriksson A. Evaluation of surgical performance with intracameral mydriatics in phacoemulsification surgery. Acta Ophthalmol Scand. 2004;82(2):144–147. doi:10.1111/j.1600-0420.2004.00241.x
  • Nikeghbali A, Falavarjani KG, Kheirkhah A, Bakhtiari P, Kashkouli MB. Pupil dilation with intracameral lidocaine during phacoemulsification. J Cataract Refract Surg. 2007;33(1):101–103. doi:10.1016/j.jcrs.2006.08.044
  • Morgado G, Barros P, Martins J, Lima A, Martins N. Comparative study of mydriasis in cataract surgery: topical versus mydriasert versus intracameral mydriasis in cataract surgery. Eur J Ophthalmol. 2010;20(6):989–993. doi:10.1177/112067211002000618
  • Labetoulle M, Findl O, Malecaze F, et al. Evaluation of the efficacy and safety of a standardised intracameral combination of mydriatics and anaesthetics for cataract surgery. Br J Ophthalmol. 2016;100(7):976–985. doi:10.1136/bjophthalmol-2015-307587
  • Chiambaretta F, Pleyer U, Behndig A, et al. Pupil dilation dynamics with an intracameral fixed combination of mydriatics and anesthetic during cataract surgery. J Cataract Refract Surg. 2018;44(3):341–347. doi:10.1016/j.jcrs.2017.12.025
  • Laboratoires Thea. Mydrane summary of product characteristics latest updated on eMC: 02 sept 2021. Mydrane 0.2 mg/mL + 3.1 mg/mL + 10 mg/mL solution for injection - Summary of Product Characteristics (SmPC) - (emc) (medecines org.UK); 2023 Available fromhttps://www.medicines.org.uk/emc/product/7254/smpc/print. Accessed June 16, 2023.
  • Segers MHM, Rosen P, van den Biggelaar FJHM, et al. Anesthesia techniques and the risk of complications as reflected in the European registry of quality outcomes for cataract and refractive surgery. J Cataract Refract Surg. 2022;48(12):1403–1407. doi:10.1097/j.jcrs.0000000000001009
  • Guzek JP, Holm M, Cotter JB, et al. Risk factors for intraoperative complications in 1000 extracapsular cataract cases. Ophthalmology. 1987;94(5):461–466. doi:10.1016/S0161-6420(87)33424-4
  • Narendran N, Jaycock P, Johnston RL, et al. The cataract national dataset electronic multicentre audit of 55,567 operations: risk stratification for posterior capsule rupture and vitreous loss. Eye. 2009;23(1):31–37. doi:10.1038/sj.eye.6703049
  • Vukicevic M, Gin T, Al-Qureshi S. Prevalence of optical coherence tomography-diagnosed postoperative cystoid macular oedema in patients following uncomplicated phaco-emulsification cataract surgery. Clin Exp Ophthalmol. 2012;40(3):282–287. doi:10.1111/j.1442-9071.2011.02638.x
  • Nazim-Lipski G, Bolsega-Pacud J, Kubicka-Trzaska A, Markiewicz A, Romanowska-Dixon B. Mydrane intracameral injection site can be an alternative to mydriatic drops instillation in cataract surgery. J Physiol Pharmacol. 2020;71(2). doi:10.26402/jpp.2020.2.08
  • Bourne RR, Minassian DC, Dart JK, Rosen P, Kaushal S, Wingate N. Effect of cataract surgery on the corneal endothelium: modern phacoemulsification compared with extracapsular cataract surgery. Ophthalmology. 2004;111(4):679–685. doi:10.1016/j.ophtha.2003.07.015
  • Miyata K, Maruoka S, Nakahara M, et al. Corneal endothelial cell protection during phacoemulsification: low- versus high-molecular-weight sodium hyaluronate. J Cataract Refract Surg. 2002;28(9):1557–1560. doi:10.1016/S0886-3350(02)01540-7
  • O’Brien PD, Fitzpatrick P, Kilmartin DJ, Beatty S. Risk factors for endothelial cell loss after phacoemulsification surgery by a junior resident. J Cataract Refract Surg. 2004;30(4):839–843. doi:10.1016/S0886-3350(03)00648-5
  • Cho YK, Chang HS, La TY, et al. Anterior segment parameters using pentacam and prediction of corneal endothelial cell loss after cataract surgery. Korea J Ophthalmology. 2010;24(5):284–290. doi:10.3341/kjo.2010.24.5.284
  • Eggeling P, Pleyer U, Hartmann C, Rieck PW. Corneal endothelial toxicity of different lidocaine concentrations. J Cataract Refract Surg. 2000;26(9):1403–1408. doi:10.1016/S0886-3350(00)00379-5
  • Chang YS, Tseng SY, Tseng SH, Wu CL. Cytotoxicity of lidocaine or bupivacaine on corneal endothelial cells in a rabbit model. Cornea. 2006;25(5):590–596. doi:10.1097/01.ico.0000220775.93852.02
  • Kim EC, Park SH, Kim MS. A comparison of pupil dilation and induction of corneal endothelial apoptosis by intracameral 1% lidocaine versus 1:100,000 epinephrine in rabbits. J Ocul Pharmacol Ther. 2010;26(6):563–570. doi:10.1089/jop.2010.0078
  • Mori Y, Miyai T, Kagaya F, et al. Intraoperative mydriasis by intracameral injection of mydriatic eye drops: in vivo efficacy and in vitro safety studies. Clin Exp Ophthalmol. 2011;39(5):456–461. doi:10.1111/j.1442-9071.2010.02456.x
  • Poyales-Galan F, Pirazzoli G. Clinical evaluation of endothelial cell decrease with VisThesia in phacoemulsification surgery. J Cataract Refract Surg. 2005;31(11):2157–2161. doi:10.1016/j.jcrs.2005.07.016
  • Rigal-Sastourne JC, Huart B, Pariselle G, et al. Diffusion de la lidocaïne après injection intracamérulaire. J Fr Ophtalmol. 1999;22(1):21–24.
  • Baudouin C, Labbe A, Liang H, Pauly A, Brignole-Baudouin F. Preservatives in eyedrops: the good, the bad and the ugly. Prog Retin Eye Res. 2010;29(4):312–334. doi:10.1016/j.preteyeres.2010.03.001
  • Soong T, Soultanidis M, Claoue C, Gallagher M, Thomson S. Safety of intracameral mydriasis in phacoemulsification cataract surgery. J Cataract Refract Surg. 2006;32(3):375–376. doi:10.1016/j.jcrs.2005.12.088
  • Guell J, Behndig A, Pleyer U, et al. Systemic exposure to intracameral vs topical mydriatic agents: in cataract surgery. Clin Ophthalmol. 2019;13:811–819. doi:10.2147/OPTH.S189671